Literature DB >> 22095247

Cervical stromal involvement can predict survival in advanced endometrial carcinoma: a review of 67 patients.

Salih Taşkın1, Fırat Ortaç, Korhan Kahraman, Göksu Göç, Derya Oztuna, Mete Güngör.   

Abstract

PURPOSE: To assess clinical, surgical and pathologic variables in survival of advanced endometrial cancer.
METHODS: Sixty-seven advanced-stage (stages III and IV according to FIGO 2009) endometrial cancer cases were evaluated retrospectively. The effects on survival of age, histologic subtype, stage, grade, myometrial invasion, optimal cytoreduction, parity and cervical involvement were analyzed.
RESULTS: Cervical involvement (P = 0.033) and nulliparity (P = 0.042) were worsening features in terms of survival. In 56 cases (83.5%) optimal cytoreduction could be achieved and survival was significantly longer in this group than the group who were not optimally cytoreduced (mean 30.4 vs. 9.6 months) (P < 0.01). Depth of myometrial invasion, histologic type of tumor, stage, grade, and age younger or older than 60 years were not found to be related to survival. Neither adjuvant therapy type nor their combination were superior to each other for improving survival.
CONCLUSIONS: Cervical stromal involvement is a poor prognostic factor in cases of advanced endometrial carcinoma. Further studies are required to describe the effect of different surgical approaches such as radical hysterectomy on survival in the presence of cervical stromal invasion.

Entities:  

Mesh:

Year:  2011        PMID: 22095247     DOI: 10.1007/s10147-011-0351-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  16 in total

1.  The role of surgical cytoreduction in Stage IV endometrial carcinoma.

Authors:  D S Chi; M Welshinger; E S Venkatraman; R R Barakat
Journal:  Gynecol Oncol       Date:  1997-10       Impact factor: 5.482

2.  Stage III and stage IV endometrial carcinoma: a review of 41 cases.

Authors:  S Pliskow; M Penalver; H E Averette
Journal:  Gynecol Oncol       Date:  1990-08       Impact factor: 5.482

3.  Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications.

Authors:  K M Greven; W J Curran; R Whittington; J Fanning; M E Randall; J Wilder; A J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

4.  Stage III and IV endometrial cancer: a 20-year review of patients.

Authors:  F H van Wijk; F J Huikeshoven; L Abdulkadir; P C Ewing; C W Burger
Journal:  Int J Gynecol Cancer       Date:  2006 Jul-Aug       Impact factor: 3.437

5.  Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.

Authors:  R E Bristow; M J Zerbe; N B Rosenshein; F C Grumbine; F J Montz
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

6.  Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.

Authors:  J G Aalders; V Abeler; P Kolstad
Journal:  Gynecol Oncol       Date:  1984-01       Impact factor: 5.482

7.  Prognostic indicators of survival in advanced endometrial cancer.

Authors:  K Behbakht; E L Yordan; C Casey; K DeGeest; L S Massad; C V Kirschner; G D Wilbanks
Journal:  Gynecol Oncol       Date:  1994-12       Impact factor: 5.482

8.  Parity and time interval since childbirth influence survival in endometrial cancer patients.

Authors:  Grethe Albrektsen; Ivar Heuch; Elisabeth Wik; Helga B Salvesen
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

9.  The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.

Authors:  A Ayhan; C Taskiran; C Celik; K Yuce; T Kucukali
Journal:  Int J Gynecol Cancer       Date:  2002 Sep-Oct       Impact factor: 3.437

10.  Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.

Authors:  Stelios Fotiou; Nikos Vlahos; Agatha Kondi-Pafiti; Petros Zarganis; Katerina Papakonstantinou; George Creatsas
Journal:  Gynecol Oncol       Date:  2008-12-30       Impact factor: 5.482

View more
  3 in total

1.  Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.

Authors:  Gigin Lin; Yu-Ting Huang; Angel Chao; Yu-Chun Lin; Lan-Yan Yang; Ren-Chin Wu; Hsin-Ying Lu; Shu-Hang Ng; Koon-Kwan Ng; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2016-09-09       Impact factor: 5.315

2.  Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix.

Authors:  Gunsu Kimyon Comert; Derman Basaran; Hayriye Ergin Akkoz; Burcin Celik; Selcan Sinaci; Osman Turkmen; Alper Karalok; Olcay Kandemir; Taner Turan
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

3.  Diagnostic Accuracy of MRI for Detecting Cervical Invasion in Patients with Endometrial Carcinoma: A Meta-Analysis.

Authors:  Qiu Bi; Guoli Bi; Junna Wang; Jie Zhang; Hongliang Li; Xiarong Gong; Lixiang Ren; Kunhua Wu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.